Advancing the Tendinopathy Triad: Comment on “Tendinopathy: The Interplay Between Mechanical Stress, Inflammation, and Vascularity”

TL;DR

This paper suggests new ways to understand and treat tendinopathy by exploring advanced biological and technological approaches.

Contribution

The paper introduces novel concepts like spatiotemporal multi-omics and 4D-bioprinted biomaterials for tendinopathy.

Findings

A paradigm shift toward multi-omics deconstruction of tendon pathology is proposed.

Epigenetic reprogramming and neuro-immune-vascular niches are highlighted as key factors.

AI-powered digital twins could enable targeted diagnostics and therapies.

Abstract

Building upon the integrative framework of tendinopathy proposed by Gehwolf et al.—which elegantly connects mechanical stress, inflammation, and vascularity—this commentary extends the discussion by introducing novel mechanistic insights and future research directions that move beyond the established triad.</mark> A paradigm shift is proposed toward spatiotemporal multi‐omics deconstruction of tendon pathology, emphasizing the role of epigenetically driven cellular re‐programming in tendon stem/progenitor cells and the emergence of neuro‐immune‐vascular niches as functional units sustaining chronicity. Furthermore, redox‐mechanobiological integration through sensors such as TNIK and the potential of 4D‐bioprinted smart biomaterials for chrono‐specific therapeutic delivery are explored. By incorporating advanced computational approaches, including AI‐powered digital tendon twins, a transformative roadmap is outlined for translating the homeostatic failure model into precisely targeted, mechanism‐based diagnostics and therapies. This perspective aims to stimulate interdisciplinary innovation and position tendinopathy research at the forefront of musculoskeletal science.